Importantly, there was no significant effect of the laboratory sites on the results of this investigation, which confirms TRPM3 as a consistent biomarker for ME/CFS. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.